132 related articles for article (PubMed ID: 8668643)
41. Inhibitory actions of captopril on norepinephrine release from adrenergic nerve endings in spontaneously hypertensive rats.
Tsuda K; Tsuda S; Ura M; Shima H; Nishio I; Masuyama Y
Jpn Heart J; 1988 Jul; 29(4):475-83. PubMed ID: 2846908
[TBL] [Abstract][Full Text] [Related]
42. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
[TBL] [Abstract][Full Text] [Related]
43. Effects of the angiotensin I converting enzyme inhibitor perindopril on cerebral blood flow in awake hypertensive rats.
Bray L; Lartaud I; Muller F; Atkinson J; Capdeville C
Am J Hypertens; 1991 Mar; 4(3 Pt 2):246S-252S. PubMed ID: 2043313
[TBL] [Abstract][Full Text] [Related]
44. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
[TBL] [Abstract][Full Text] [Related]
45. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Intengan HD; Thibault G; Li JS; Schiffrin EL
Circulation; 1999 Nov; 100(22):2267-75. PubMed ID: 10578002
[TBL] [Abstract][Full Text] [Related]
46. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Black MJ; Kanellakis P; Bobik A
J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
[TBL] [Abstract][Full Text] [Related]
47. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
Dharmani M; Mustafa MR; Achike FI; Sim MK
Eur J Pharmacol; 2007 Apr; 561(1-3):144-50. PubMed ID: 17320855
[TBL] [Abstract][Full Text] [Related]
48. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
49. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
[TBL] [Abstract][Full Text] [Related]
50. Effect of captopril on intracellular free calcium ([Ca2+]i) of thymocytes in spontaneously hypertensive rats.
Xie L; Chen D; Wu D; Wang H
J Hum Hypertens; 1996 Jun; 10(6):425-7. PubMed ID: 8872812
[TBL] [Abstract][Full Text] [Related]
51. Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension.
Chang HR; Lee RP; Wu CY; Chen HI
Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):275-80. PubMed ID: 11985535
[TBL] [Abstract][Full Text] [Related]
52. Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat.
Berecek KH; Okuno T; Nagahama S; Oparil S
Hypertension; 1983; 5(5):689-700. PubMed ID: 6413405
[TBL] [Abstract][Full Text] [Related]
53. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
54. Effects of chronic administration of sarpogrelate on systolic blood pressure of spontaneously hypertensive rats: comparison with quinapril.
Setoguchi Y; Ohnuki T; Rashid M; Nakamura T; Hattori K; Nagatomo T; Watanabe K; Mitomi A; Nakazawa M
Pharmacology; 2002 Feb; 64(2):71-5. PubMed ID: 11803246
[TBL] [Abstract][Full Text] [Related]
55. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
56. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
Kost CK; Herzer WA; Li P; Jackson EK
J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
[TBL] [Abstract][Full Text] [Related]
57. Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats.
Hu WY; Han YJ; Gu LZ; Piano M; de Lanerolle P
Am J Hypertens; 2007 Jan; 20(1):53-61. PubMed ID: 17198912
[TBL] [Abstract][Full Text] [Related]
58. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
Muratani H; Takishita S; Kawazoe N; Tozawa M; Fukiyama K
Blood Press Suppl; 1992; 3():60-7. PubMed ID: 1343293
[TBL] [Abstract][Full Text] [Related]
59. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril.
Wu JN; Berecek KH
Hypertension; 1993 Aug; 22(2):139-46. PubMed ID: 8340149
[TBL] [Abstract][Full Text] [Related]
60. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.
Li JS; Schiffrin EL
J Cardiovasc Pharmacol; 1996 Jul; 28(1):68-74. PubMed ID: 8797138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
